Curanex Pharmaceuticals Inc Common Stock (CURX) NASDAQ

0.46

+0.1444(+45.77%)

Updated at February 26 04:00PM

Currency In USD

Valuation

Market Cap111.55M
Enterprise Value111.41M
P/E Ratio-9.13
PEG Ratio0.02
Price/Sales Ratio0
Price/Book Ratio0.82
Enterprise/Revenue0
Enterprise/EBITDA-6.25

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.33

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-290,386
Net Income-361,506
Diluted EPS-0.01

Balance Sheet

Total Cash5.83M
Total Cash/Share0.23
Total Debt61,150
Total Debt/Equity0
Current Ratio77.53
Book Value Per Share0.56

Price History

52-Week Change-88.56
52-Week High9.18
52-Week Low0.28
Moving Average 50 Days0.39
Moving Average 200 Days1.4

Statistics

Average Volume224,875
Shares Outstanding28.34M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A